Abstract:Lotte Sahin Levison, 1 Peter Jepsen, 2, 3 Henning Andersen 1 1 Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; 2 Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; 3 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark Correspondence: Lotte Sahin Levison, Department of Neurology, Aarhus University Hospital, Palle Juul–Jensens Boulevard 165, Aarhus, 8200, Denmark, Tel +45 26807160, Fax +4578463300, Email Purpose: Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR). Patients and Methods: We obtained data from the DNPR for all adult (> 17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis. Results: Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1– 92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥ 70 years (93.8; 95% CI: 86.2– 97.3) compared to patients < 60 years (83.4; 95% CI: 73.3– 90.7). Conclusion: We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS. Keywords: registries, positive predictive value, international classification of disease codes, epidemiology, amyotrophic lateral sclerosis Amyotrophic lateral sclerosis (ALS) is a rare disease characterized by progressive motor neuron degeneration, with a reported incidence rate between 2.1 and 3.8 per 100,000 persons per year in Europe. 1 Death from ALS is usually due to respiratory failure and occurs within one to four years from diagnosis. 2 Advances have been made in understanding the genetic background for ALS; however, only up to 10% of cases are genetically inherited. 2,3 The underlying etiology of sporadic ALS remains poorly understood, and identification of risk factors for ALS has proven difficult. 1,4 Yet suspicion has been raised, that environmental factors may contribute to ALS risk. 3,5 Many studies addressing ALS risk factors rely on hospital discharge diagnosis codes recorded in administrative health care databases. 2,6 Use of these databases for epidemiological research can be a cost-efficient way of collecting data on ALS. 1,7 National databases in Denmark may provide exact estimates of effect and enable studying of rare exposures or outcomes. The risks of recall bias and non-response are reduced; however, the usability of these databases relies heavily on the validity of the registered data. 7,8 Thus, to draw valid inferences from database studies on ALS, the validity of the diagnosis needs to be determined. 1,7,8 In our study, we examined the quality of ALS discharge diagnosis in the population–based Danish National Patient Registry (DNPR) by estimating the positive predictive value (PPV) using medical record data as a reference standard. Furthermore, we determined whether the validity of the ALS diagnosis varied by year of diagnosis, sex, and patient age. Denmark has 5.9 million citizens, and the country is divided into five regions. 9 The Danish National Health Service provides all inhabitants with tax–supported health care. Since 1968, all Danish citizens have been registered in the Danish Civil Registration System and given a unique 10–digit civil registry number (CPR number). 8 This number contains information on birth date and sex and enables unique identification and matching of registry data at the individual level. The DNPR was established in 1977 and contains data on all hospital admissions, including CPR number, admission and discharge dates, hospital department, primary discharge diagnosis code (the primary reason for hospitalization), and secondary diagnosis codes. 7 All neurological hospital care is provided by 14 neurological departments located at five univer -Abstract Truncated-

Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK

Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank

Prevalence of amyotrophic lateral sclerosis in the United States, 2018

Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis

Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in Wales

Incidence and prevalence of Amyotrophic Lateral Sclerosis in three Italian Regions: a study based on health administrative databases

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm

A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis

Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

A machine-learning based objective measure for ALS disease severity

Pharmacological and non‐pharmacological treatments in amyotrophic lateral sclerosis: an Italian real‐world data study

Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials

Medication use and risk of amyotrophic lateral sclerosis: using machine learning for an exposome-wide screen of a large clinical database

Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry

Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction

Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis

Author Correction: Common and Rare Variant Association Analyses in Amyotrophic Lateral Sclerosis Identify 15 Risk Loci with Distinct Genetic Architectures and Neuron-Specific Biology

Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol

Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS